SCHEMBL2929416

SCHEMBL2929416

COc1ccc2c(c1)oc1c3cccc(C(=O)O)c3[nH]c21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.53
CA1 P00915 2/20 0.53
CA2 P00918 2/20 0.53
CA3 P07451 2/20 0.53
CA5A P35218 2/20 0.53
CA7 P43166 2/20 0.53
CA9 Q16790 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA5B Q9Y2D0 2/20 0.53
CA4 P22748 1/20 0.53
MAOA P21397 2/20 0.48
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 5/20 0.48
L3MBTL1 Q9Y468 3/20 0.47
RAB9A P51151 2/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.47
PPARG P37231 1/20 0.47
KMT2A Q03164 1/20 0.47
NCOA2 Q15596 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2926491 0.81 KCNMA1 (0.50) KDM4EALDH1A1L3MBTL1LMNAMAPT
SCHEMBL2924487 0.81 KDM4E (0.52) CA12CA1CA2CA3CA5A
SCHEMBL7498157 0.81 CA12 (0.41) CA12CA1CA2CA3CA5A
SCHEMBL7500797 0.81 KCNMA1 (0.43) CA12CA1CA2CA3CA5A
SCHEMBL2933540 0.79 KCNMA1 (0.67) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL5470345 0.76 RAB9A (0.58) CA1CA2MAOAKDM4EALDH1A1
SCHEMBL17284920 0.76 KMT2A (0.68) MAOAKDM4EALDH1A1L3MBTL1RAB9A
SCHEMBL11733627 0.75 KDM4E (0.60) KDM4EALDH1A1L3MBTL1RAB9APOLB
SCHEMBL7505833 0.74 PBRM1 (0.44) MAOAKDM4EALDH1A1MEN1KMT2A
SCHEMBL7503751 0.74 CA12 (0.42) CA12CA1CA2CA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812177-B2 Potassium channel opener having benzofuroindole skeleton ANYGEN CO., LTD. (KR) 2010-10-12 US disclosed
EP-1861092-B1 POTASSIUM CHANNEL OPENER HAVING BENZOFUROINDOLE SKELETON ANYGEN CO LTD (KR) 2010-09-15 EP disclosed
EP-1861092-A4 POTASSIUM CHANNEL OPENER HAVING BENZOFUROINDOLE SKELETON ANYGEN CO LTD (KR) 2009-04-15 EP disclosed
US-20080194837-A1 Potassium Channel Opener Having Benzofuroindole Skeleton ANYGEN CO., LTD. (KR) 2008-08-14 US disclosed
EP-1861092-A1 POTASSIUM CHANNEL OPENER HAVING BENZOFUROINDOLE SKELETON Anygen Co., Ltd. (KR) 2007-12-05 EP disclosed
WO-2006096030-A1 POTASSIUM CHANNEL OPENER HAVING BENZOFUROINDOLE SKELETON ANYGEN CO., LTD. (KR) 2006-09-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194837-A1 Potassium Channel Opener Having Benzofuroindole Skeleton KCNJ2, KCNN3, KCNH2 CA12 2649/4885CA1 1446/4885CA2 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.